Home
News
Create
Screeners
Insights
Mahamaya Lifesciences
172.
65
+8.35
(+5.08%)
Market Cap
₹404.04 Cr
PE Ratio
29.71
Industry
Chemicals
Buy
Sell
Company Performance:
1D
+5.08%
1M
+7.54%
6M
+48.84%
1Y
+48.84%
5Y
+48.84%
View Company Insights
Latest news about Mahamaya Lifesciences
Mahamaya Lifesciences Files Quarterly Compliance Certificate for Q4FY26 Under SEBI Regulations
6 days ago
Mahamaya Lifesciences Limited submitted its Q4FY26 compliance certificate under SEBI Regulation 74(5) to BSE on April 4, 2026. KFin Technologies Limited, the company's registrar, confirmed the regulation is not applicable as all shares remain in demat form with no rematerialization requests received during the quarter ended March 31, 2026. Company Secretary Shilpi Bhardwaj signed the submission, demonstrating continued regulatory compliance.
Mahamaya Lifesciences Confirms No Share Encumbrance by Promoters in FY26
7 days ago
Mahamaya Lifesciences Extends IPO Proceeds Utilisation Timeline to March 2028
Mar 10, 2026
Mahamaya Lifesciences Withdraws from Arihant Capital Virtual Conference Due to Scheduling Constraints
Mar 09, 2026
Mahamaya Lifesciences Limited Receives 'Company of the Year – Medium Scale' Award at ICSCE 2026, Dubai
Jan 22, 2026
More news about Mahamaya Lifesciences
17
Dec 25
Vijay Kedia Acquires 8.91 Lakh Shares in Mahamaya Lifesciences at ₹140 Per Share
Investor Vijay Kedia has purchased 8.91 lakh shares of Mahamaya Lifesciences, an SME-listed agro chemicals company, at ₹140 per share. The total investment amounts to ₹12.47 crores, representing a substantial stake in the small-cap firm. This move has drawn attention to the company and the agro chemicals sector.
02
Dec 25
Mahamaya Lifesciences Reports 17.6% Profit Growth in H1 FY26
Mahamaya Lifesciences, a provider of agricultural crop protection solutions, announced unaudited financial results for H1 FY26. Revenue from operations increased by 11.5% to ₹16,306.37 lakhs. Standalone profit rose by 17.6% to ₹852.56 lakhs. Earnings per share improved by 7.1% to ₹4.80. The results were approved by the Board of Directors on December 02, 2025. The company's performance indicates strong market position and increasing demand for its products in the agricultural sector.
Mahamaya Lifesciences
172.
65
+
8.
35
(+
5.
08
%)
1 Year Returns:
+48.84%
Industry Peers
UPL
644.85
(+
0.
44
%)
PI Industries
2,952.10
(+
2.
48
%)
Bayer Crop Science
4,805.30
(-
0.
07
%)
Sumitomo Chemical
418.60
(+
0.
83
%)
Sharda Cropchem
1,057.25
(+
2.
28
%)
Rallis
258.20
(+
1.
07
%)
Dhanuka Agritech
1,025.10
(+
1.
53
%)
NACL Industries
166.26
(-
0.
51
%)
Bhagiradha Chemicals & Industries
222.36
(+
0.
72
%)
Bharat Rasayan
1,570.00
(+
6.
94
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO